Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment
Nakho Chang, Sun Hee Ahn, Doo‐Sik Kong, et al.
Molecular and Cellular Endocrinology (2017) Vol. 451, pp. 53-65
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
Li Yang, Aitian Li, Qingyang Lei, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 165
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
Astrid De Boeck, Bo Young Ahn, Charlotte D’Mello, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 146
Flavonoid Rutin Presented Anti-Glioblastoma Activity Related to the Modulation of Onco miRNA-125b Expression and STAT3 Signaling and Impact on Microglia Inflammatory Profile
Irlã Santos Lima, Érica Novaes Soares, Carolina Kymie Vasques Nonaka, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 90-90
Open Access | Times Cited: 30
Homoharringtonine: mechanisms, clinical applications and research progress
Wen Wang, Lan He, Ting Lin, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 3
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Anaëlle Dumas, Nicola Pomella, Gabriel Rosser, et al.
The EMBO Journal (2020) Vol. 39, Iss. 15
Open Access | Times Cited: 115
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
Luqing Tong, Jiabo Li, Qiuying Li, et al.
Theranostics (2020) Vol. 10, Iss. 13, pp. 5943-5956
Open Access | Times Cited: 113
Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
Christina Piperi, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Cells (2019) Vol. 8, Iss. 11, pp. 1398-1398
Open Access | Times Cited: 94
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
Nikhil Pandey, Pavlos Anastasiadis, Christine P. Carney, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114415-114415
Open Access | Times Cited: 41
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research (2023) Vol. 233, pp. 116458-116458
Closed Access | Times Cited: 23
Mutations in the signal transducer and activator of transcription family of genes in cancer
Nahid Shahmarvand, Alexandra Nagy, Jahanbanoo Shahryari, et al.
Cancer Science (2018) Vol. 109, Iss. 4, pp. 926-933
Open Access | Times Cited: 80
The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
Karam Khaddour, Tanner M. Johanns, George Ansstas
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 389-389
Open Access | Times Cited: 60
De novopurine biosynthesis is a major driver of chemoresistance in glioblastoma
Jack Shireman, Fatemeh Atashi, Gina Lee, et al.
Brain (2021) Vol. 144, Iss. 4, pp. 1230-1246
Open Access | Times Cited: 56
Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment
Soohyun Hong, Jae Young You, Kyurim Paek, et al.
Theranostics (2021) Vol. 11, Iss. 19, pp. 9687-9704
Open Access | Times Cited: 50
TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas
Jiabo Li, Xuya Wang, Lulu Chen, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 8-9, pp. 1117-1129
Open Access | Times Cited: 30
Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths
Sepideh Karkon Shayan, Hasan Aliashrafzadeh, Hassan Dianat‐Moghadam, et al.
Acta Histochemica (2023) Vol. 125, Iss. 6, pp. 152058-152058
Closed Access | Times Cited: 17
The STAT3/Slug Axis Enhances Radiation-Induced Tumor Invasion and Cancer Stem-like Properties in Radioresistant Glioblastoma
Jang-Chun Lin, Jo-Ting Tsai, Tsu-Yi Chao, et al.
Cancers (2018) Vol. 10, Iss. 12, pp. 512-512
Open Access | Times Cited: 59
Current Advances in Immunotherapy for Glioblastoma
Abigail Mende, Jessica Schulte, Hideho Okada, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 40
Quercetin Induces Apoptosis in Glioblastoma Cells by Suppressing Axl/IL-6/STAT3 Signaling Pathway
Hyo In Kim, Sol Ji Lee, Yu-Jeong Choi, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 03, pp. 767-784
Closed Access | Times Cited: 39
Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation
Xiaoqing Fan, Haoran Yang, Chenggang Zhao, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 33
EZH2‐associated tumor malignancy: A prominent target for cancer treatment
Maryam Sabour Takanlou, Leila Sabour Takanlou, Çiğir Biray-Avci
Clinical Genetics (2024) Vol. 106, Iss. 4, pp. 377-385
Open Access | Times Cited: 6
Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways
Fabliha Ahmed Chowdhury, Md Kamal Hossain, AGM Mostofa, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 42
Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
Muhammad Nadeem Abbas, Saima Kausar, Hongjuan Cui
Clinical & Translational Oncology (2019) Vol. 22, Iss. 7, pp. 963-977
Closed Access | Times Cited: 40
Pimozide Suppresses the Growth of Brain Tumors by Targeting STAT3-Mediated Autophagy
Alok Ranjan, Itishree Kaushik, Sanjay Srivastava
Cells (2020) Vol. 9, Iss. 9, pp. 2141-2141
Open Access | Times Cited: 37
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation
Marta Chiavari, Gabriella Maria Pia Ciotti, Francesco Canonico, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8214-8214
Open Access | Times Cited: 33
STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
Liang Zhang, Cody L. Nesvick, Charles Day, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 10, pp. 1700-1711
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top